Michael F. Mahoney
Chairman, President & CEO at Boston Scientific; Director at Baxter International; Director at CVS Health. Based in Marlborough, Massachusetts.
- Rank
- 1764th of 14,452
- Companies held
- 3
- Largest holding
- BSX, 98.4% of total
- Latest SEC filing
- Nov 4, 2026
What the $81.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Boston Scientific BSX Common Stock | Directly | 1,590,024 | $42.99 | $68.4M | 83.9% | Form 4, Nov 4, 2026 |
| Boston Scientific BSX Common Stock | Through Trust | 252,241 | $42.99 | $10.8M | 13.3% | Form 4, Nov 4, 2026 |
| Boston Scientific BSX Common Stock | Through 401(k) | 22,112 | $42.99 | $951K | 1.2% | Form 4, Nov 4, 2026 |
| Baxter International BAX Common Stock, $1 par value | Shares owned by Michael F. Mahoney Revocable Trust | 20,397 | $25.39 | $518K | 0.6% | Form 4, May 2, 2023 |
| CVS Health CVS Common Stock | Directly | 6,345 | $80.04 | $508K | 0.6% | Form 4, May 15, 2025 |
| Baxter International BAX Common Stock, $1 par value | Directly | 9,692 | $25.39 | $246K | 0.3% | Form 4, May 2, 2023 |
| CVS Health CVS Common Stock (By Trust) | Through Children's Trusts | 210 | $80.04 | $17K | 0.0% | Form 4, Feb 18, 2025 |
Share counts are the amounts Michael F. Mahoney reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1761 | Robert E. Coletti Director, Cintas. Cincinnati, OH | $81.6M |
| 1762 | Shawn Henry CHIEF SECURITY OFFICER, CrowdStrike Holdings. New York, NY | $81.6M |
| 1763 | Nelson Knight President Real Estate & Invest, Apple Hospitality REIT. Richmond, VA | $81.5M |
| 1764 | Michael F. Mahoney Chairman, President & CEO, Boston Scientific. Marlborough, MA | $81.4M |
| 1765 | Joseph P. Lyssikatos CHIEF SCIENTIFIC OFFICER, Enliven Therapeutics. Boulder, CO | $81.3M |
| 1766 | Lloyd D. Frink Co -Exec. Chairman & President, Zillow Group. Seattle, WA | $81.3M |
| 1767 | Michael Eugene McBride Chief Revenue Officer, GitLab. Not Applicable, DE | $81.2M |
Other Boston Scientific insiders
All BSX insiders- Joseph Michael Fitzgerald$12.2MEVP & Group Pres, Cardiology. #7577 overall
- Daniel J. Brennan$9.7MEVP and CFO. #8006 overall
- Maulik Nanavaty$7.6MSVP & Pres, Neuromodulation. #10722 overall
- Charles Dockendorff$2.7MDirector. #4954 overall
- David S. Wichmann$2.0MDirector. #3332 overall
- Nelda J. Connors$1.6MDirector. #14149 overall
Questions
How much stock does Michael F. Mahoney own?
Michael F. Mahoney holds $81,438,189 in listed stock based on SEC filings and current prices, mostly Boston Scientific (BSX). That ranks 1764th on the Stock Rich List.
Is this Michael F. Mahoney's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Michael F. Mahoney last buy or sell stock?
The most recent open-market trade on file is a purchase of 186,240 BSX shares on Aug 3, 2026 at $48.33.